Iridium Communications Announces Proxy Filing for Rocket Lab Merger

What Happened

• Iridium Communications Inc. filed its definitive proxy statement on August 26, 2026 relating to the proposed two-step merger with Rocket Lab Corporation under a Merger Agreement dated June 28, 2026. The special meeting of Iridium stockholders is scheduled for September 24, 2026 (record date: August 21, 2026). If conditions are met (including shareholder approval), Iridium expects to complete the Mergers in mid-2027.
• The company disclosed three lawsuits filed by purported stockholders in New York alleging disclosure deficiencies in the proxy and also reported receipt of related demand letters. Iridium says the claims are without merit but is voluntarily supplementing the proxy to moot the disclosure claims and avoid delay or distraction.
• The filing notes the Form S-4 registration statement was declared effective on August 26, 2026 and the definitive proxy/final prospectus was distributed beginning on or about that date.

Key Details

• Special meeting: September 24, 2026 at 8:30 a.m. ET; record date August 21, 2026. Expected closing: mid-2027 (subject to conditions).
• Merger consideration implied value: $54.00 per share of Iridium common stock.
• Selected valuation metrics and updates in the supplement to Evercore’s analyses:
  • Selected precedent transactions TEV / LTM Adjusted EBITDA multiple range: 10.0x–14.0x; Iridium estimated LTM Adjusted OEBITDA (6/30/2026): ~$527M; estimated net debt: ~$2,102M; fully diluted shares (6/24/2026): ~110.5M; implied equity value per share range from that analysis: $28.69–$47.77.
  • Discounted cash flow analysis terminal growth: 2.5%–3.5%; discount rates: 9.0%–10.0%; present-value DCF implied equity per-share range: $29.97–$45.54; present value of NOLs/R&D tax credits estimated at ~$244M (discounted at 11.0%).
  • Rocket Lab analyses: implied equity per-share ranges varied by method (examples: $61.22–$99.03 based on 2027 revenue; PV of future share price analysis: $46.23–$102.45).
• Market comparators and analyst targets cited: Iridium analyst price-target ranges $16–$40 (4/1/2026) and $16–$60 (6/26/2026); Rocket Lab analyst targets $60–$150 (6/26/2026).

Why It Matters

• Shareholder vote required: Iridium stockholders must approve the transaction at the September 24 meeting for the Mergers to proceed; the company’s timetable targets mid-2027 closing if all conditions (including regulatory approvals) are satisfied.
• Litigation and demand letters could delay or seek to enjoin the transaction; Iridium has chosen to supplement its proxy statements to address alleged disclosure issues while denying legal merit to the claims. That action is intended to reduce nuisance litigation risk and avoid delays that could affect timing and certainty of the deal.
• Financial context: the filing provides updated valuation analyses and target ranges that investors can use to compare the $54 implied merger consideration against market prices, analyst targets and independent valuation ranges cited by Evercore. Investors should read the definitive proxy/final prospectus and risk factors filed with the SEC for full details.